Speaker Biography

Joel I. Osorio

CEO & Founder -Regenerative Medicine and Functional Nutrition Clinic , USA

Title: RegenerAge System: Therapeutic effects of combinatorial biologics (mRNA and allogenic MSCs) with a spinal cord stimulation system on a patient with spinal cord section.

 Joel I. Osorio
Biography:

International speaker on Biotechnology (mRNA) and its clinical applications with "No Option" patients. Served in various capacities in private and public practices throughout Mexico. MD degrees at Westhill University and the National Autonomous University of Mexico as qualified Physician Surgeon. Visiting Scholar in Dermatology, at the University of North Carolina, Chapel Hill. Advanced Fellow with the American Board of Anti-Ageing and Regenerative Medicine, Fellow in Stem Cell Medicine with both the American Academy of Anti-Ageing Medicine and University of South Florida. Master in Health Sciences at Aged Services Victoria University. Business Diplomate by the Einstein College of Australia.

Abstract:

As it has been previously demonstrated that coelectroporation of Xenopus laevis frog oocytes with normal cells and cancerous cell lines induces the expression of pluripotency markers and in experimental murine model studies that mRNA extract (Bioquantine®) purified from intra and extra-oocyte liquid phases of electroporated oocytes) showed potential as a treatment for a wide range of conditions, including Spinal Cord Injury (SCI) among others. The current study observed beneficial changes with Bioquantine® administration in a patient with a severe SCI. Pluripotent stem cells have therapeutic and regenerative potential in clinical situations CNS disorders even cancer. One method of reprogramming somatic cells into pluripotent stem cells is to expose them to extracts prepared from Xenopus laevis oocytes. The positive human findings for spinal cord injury with the results from previous animal studies with experimental models of traumatic brain injury and SCI respectively as our evidence and due to ethical reasons, legal restrictions and a limited number of patients, we were able to treat only a very small number of patients, deciding to include in our protocol the RestoreSensor SureScan to complete it. Based on the electrical stimulation for rehabilitation and regeneration after spinal cord injury published by Hamid and MacEwan, we designed an improved delivery method for the in-situ application of MSCs and Bioquantine® in combination with the RestoreSensor® SureScan®. To the present day the patient who suffered a complete section of spinal cord at T12-L1 shows an improvement in sensitivity, strength in striated muscle and smooth muscle connection, 13 months after the first treatment and 6 months after the placement of RestoreSensor® at the level of the lesion, showing an evident improvement on his therapy of physical rehabilitation (legs movement) on crawling forward and backwards and standing on his feet for the first time and showing a progressively important functionality on both limbs.